Mitsubishi Tanabe Pharma CorporationYokohama, Japan
Pharmacology, Drug discovery research
0934: Anti-fibrotic Effects of MT-5562, a Novel Potent Selective Autotaxin Inhibitor, in Preclinical Studies: Roles of Lysophosphatidic Acid in Autoimmune Diseases and Clues to Treat Skin and Lung Fibrosis in Systemic Sclerosis
Monday, November 13, 20239:00 AM – 11:00 AM PT
Disclosure information not submitted.